SEC Form 4 · accession 0001144204-18-018996
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Marken
Officer — SVP Ops & Prod Dev
Period of report
Mar 31, 2018
Accepted (ET)
Apr 3, 2018 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 31, 2018 | F | 278 | $58.22 | D | 65,192 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported.